Evidence map›Paper›PMID 25850664›Full record

ArticleHippocampus2015

Fluoxetine induces input-specific hippocampal dendritic spine remodeling along the septotemporal axis in adulthood and middle age.

Kathleen McAvoy, Craig Russo, Shannen Kim, Genelle Rankin, Amar Sahay

Abstract read
In one paragraph

Article in Hippocampus, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Antidepressant-like effects of theFrontiers in pharmacology · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. 5-HTRMolecular brain · 2018
    Article
  15. Article
  16. Impact of Traumatic Brain Injury on Neurogenesis.Frontiers in neuroscience · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Kathleen McAvoyCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Craig RussoCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Shannen KimCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Genelle RankinCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Amar SahayCenter for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Harvard University · USCenter for Systems Biology · USMassachusetts General Hospital · US

Funding

Molecular control of excitation-inhibition balance to encode ambiguous threatsR01MH104175 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SAHAY, AMAR · 2014 to 2018
$2.7M
Harnessing Adult Hippocampal Neurogenesis to Enhance Learning and Modulate MoodR00MH086615 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI SAHAY, AMAR · 2011 to 2013
$720k
NIMH NIH HHS 1-R01MH104175NIMH NIH HHS R00 MH086615NIMH NIH HHS R01 MH104175
6 · The paper itself

Abstract

Fluoxetine, a selective serotonin-reuptake inhibitor (SSRI), is known to induce structural rearrangements and changes in synaptic transmission in hippocampal circuitry. In the adult hippocampus, structural changes include neurogenesis, dendritic, and axonal plasticity of pyramidal and dentate granule neurons, and dedifferentiation of dentate granule neurons. However, much less is known about how chronic fluoxetine affects these processes along the septotemporal axis and during the aging process. Importantly, studies documenting the effects of fluoxetine on density and distribution of spines along different dendritic segments of dentate granule neurons and CA1 pyramidal neurons along the septotemporal axis of hippocampus in adulthood and during aging are conspicuously absent. Here, we use a transgenic mouse line in which mature dentate granule neurons and CA1 pyramidal neurons are genetically labeled with green fluorescent protein (GFP) to investigate the effects of chronic fluoxetine treatment (18 mg/kg/day) on input-specific spine remodeling and mossy fiber structural plasticity in the dorsal and ventral hippocampus in adulthood and middle age. In addition, we examine levels of adult hippocampal neurogenesis, maturation state of dentate granule neurons, neuronal activity, and glutamic acid decarboxylase-67 expression in response to chronic fluoxetine in adulthood and middle age. Our studies reveal that while chronic fluoxetine fails to augment adult hippocampal neurogenesis in middle age, the middle-aged hippocampus retains high sensitivity to changes in the dentate gyrus (DG) such as dematuration, hypoactivation, and increased glutamic acid decarboxylase 67 (GAD67) expression. Interestingly, the middle-aged hippocampus shows greater sensitivity to fluoxetine-induced input-specific synaptic remodeling than the hippocampus in adulthood with the stratum-oriens of CA1 exhibiting heightened structural plasticity. The input-specific changes and circuit-level modifications in middle-age were associated with modest enhancement in contextual fear memory precision, anxiety-like behavior and antidepressant-like behavioral responses.

Indexed as

Age FactorsAnimalsCA1 Region, HippocampalDendritic SpinesDentate GyrusFemaleFluoxetineMiceMice, Inbred C57BLMice, TransgenicNeurogenesisNeuronsPyramidal CellsSelective Serotonin Reuptake InhibitorsFluoxetineSelective Serotonin Reuptake InhibitorsagingCA1dematurationdendritic spinesdentate gyrusfluoxetinehippocampusneurogenesis

Identifiers

PMID25850664
PMCPMC4596739
OpenAlexW1956434663

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.